首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组海葵溶细胞素及平颏海蛇磷脂酶A2对血管外膜成纤维细胞增殖的影响
引用本文:欧阳平,姜孝玉,杨文利,赖文岩,徐安龙.重组海葵溶细胞素及平颏海蛇磷脂酶A2对血管外膜成纤维细胞增殖的影响[J].南方医科大学学报,2004,24(2):158-160.
作者姓名:欧阳平  姜孝玉  杨文利  赖文岩  徐安龙
作者单位:1. 第一军医大学南方医院心血管内科, 广东, 广州, 510515;2. 中山大学生命科学学院国家高技术计划海洋生物功能基因组开放实验室, 广东, 广州, 510275
基金项目:国家863计划项目(2001AA628090),广州市科委科技攻关引导项目(2002z3-C7111)~~
摘    要:目的 观察重组海葵溶细胞素(rSrc)及平颏海蛇磷脂酶A2(rPLA2)对成纤维细胞增殖的影响。方法 体外培养成纤维细胞,应用不同浓度的rSrc和rPLA2分别进行作用并设立对照进行比较,采用非放射性的MTS/PES法确定成纤维细胞的增殖状态。结果 各组细胞增殖率分别为:对照组0.840±0.061、rSrc 100 μg/ml组0.263±0.044、rSrc 10 μg/ml组0.418±0.054、rSrc 1 μg/ml组0.605±0.063、rSrc 100 ng/ml组0.772±0.054、rSrc 10 ng/ml组0.906±0.072、rPLA2 100 μg/ml组0.498±0.076、rPLA2 10 μg/ml组0.937±0.112、rPLA2 1 μg/ml组0.978±0.145。统计分析显示,低至1 μg/ml的rSrc仍能明显抑制大鼠成纤维细胞的增殖(P<0.01),并呈现剂量依赖性(P<0.05)。rPLA2 100 μg/ml组与对照组相比细胞增殖率有显著差异(P<0.05);rPLA2 10 μg/ml和rPLA2 1 μg/ml组与对照组相比均无显著差异(P>0.05)。结论 rSrc和rPLA2分别对血管外膜成纤维细胞增殖有一定的抑制作用。

关 键 词:成纤维细胞  重组海葵溶细胞素  重组磷脂酶A2  细胞增殖
文章编号:1000-2588(2004)02-0158-03
修稿时间:2003年10月25

Effects of recombinant Sagartia rosea cytolysin and Lapemis hardwickii phospholipase A2 on adventitial fibroblasts proliferation
OUYANG Ping,JIANG Xiao-yu,YANG Wen-li,LAI Wen-yan,XU An-long.Effects of recombinant Sagartia rosea cytolysin and Lapemis hardwickii phospholipase A2 on adventitial fibroblasts proliferation[J].Journal of Southern Medical University,2004,24(2):158-160.
Authors:OUYANG Ping  JIANG Xiao-yu  YANG Wen-li  LAI Wen-yan  XU An-long
Institution:OUYANG Ping1,JIANG Xiao-yu2,YANG Wen-li2,LAI Wen-yan1,XU An-long2 1Department of Cardiology,Nanfang Hospital,First Military Medical University,Guangzhou 510515,China, 2State Open Laboratory for Marine Functional Genomics,School of Life Science,Sun Yat-sen University,Guangzhou 510275,China
Abstract:Objective To observe the effects of recombinant Sagartia rosea cytolysin (rSrc) and Lapemis hardwickii phospholipase A2(rPLA2) on adventitial fibroblasts proliferation. Methods NIH-3T3 cells were cultured and treated with rSrc and rPLA2 at different concentrations for observation of cell proliferation using non-radioactive MTS/PES assay in comparison with the control group. Results The ratio of cell proliferation was 0.840±0.061 in the control group, and was 0.263±0.044, 0.418±0.054, 0.605±0.063, 0.772±0.054 and 0.906±0.072 in rSrc groups corresponding to rSrc concentrations of 100, 10, 1 μg/ml and 100, 10 ng/ml respectively. rSrc was found to significantly inhibit fibroblast proliferation in a dose-dependent manner when the concentration used was above 1 μg/ml (P<0.05), as compared with the control group (P<0.05). The ratio of cell proliferation was 0.498±0.076, 0.937±0.112 and 0.978±0.145 in rPLA2 groups corresponding to rPLA2 concentrations of 100, 10, 1 μg/ml respectively, indicating that rPLA2 also significantly inhibited fibroblast proliferation at the concentration of 100 μg/ml (P<0.05). Conclusion rSrc and rPLA2 can both significantly inhibit adventitial fibroblast proliferation.
Keywords:fibroblast  recombinant Sagartia rosea cytolysin  recombinant phospholipase A2  cell proliferation
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《南方医科大学学报》浏览原始摘要信息
点击此处可从《南方医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号